Avi Oler | Vice President, Corporate Development & General Counsel |
Steve Fruchtman | President & Chief Executive Officer |
Mark Guerin | Chief Financial Officer |
Ric Woodman | Chief Medical Officer |
Joe Pantginis | H.C. Wainwright |
Naureen Quibria | Maxim Group |
Ahu Demir | Noble Capital |
Yale Jen | Laidlaw & Company |
Ladies and gentlemen, thank you for standby. And welcome to the Onconova Therapeutics' First Quarter 2020 Earnings and Corporate Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host Mr.